Discovery Across the Oncology Spectrum
Every tumor is unique. Illumina next-generation sequencing (NGS) solutions can help you find the right approach, from single gene to comprehensive analysis, and go from insights to action.
Our TruSight Oncology 500 solution gives you pan-cancer coverage that was developed to align with key guidelines and evaluate DNA and RNA tumor biomarkers, including the immuno-oncology biomarkers tumor mutational burden (TMB) and microsatellite instability (MSI).
Cancer Research Products and Services
Products and Services for Cancer Studies
Illumina products and services facilitate cancer research by enabling the identification of genomic changes such as:
- Germline and somatic variants
- Gene fusions
- Copy number variants
- RNA expression changes
- Epigenetic alterations
Illumina cancer research products support both NGS and microarray strategies for various study designs.
Cancer Research Products
Illumina offers a wide variety of sequencing and microarray products for cancer research.
Featured Products:
- AmpliSeq for Illumina BRCA Panel – Targeted research panel investigating somatic and germline variants in BRCA1 and BRCA2.
- AmpliSeq for Illumina Focus Panel – Targeted DNA and RNA research panel investigating 52 genes with known relevance to solid tumors.
- AmpliSeq for Illumina Immune Response Panel – Targeted RNA expression research panel investigating 395 genes involved in tumor-immune system interactions.
- TruSight Tumor 170 – Comprehensive panel detects single-nucleotide variants (SNVs), amplifications, and fusions that contribute to solid tumor progression.
- TruSight Oncology 500 – Expansion of TruSight Tumor 170 content and assessment capabilities, aggregating to 523 genes, with enough genomic content to enable robust MSI and TMB evaluation
- TruSight Oncology UMI Reagents – The TruSight Oncology UMI Reagents reduce error rates in samples to ≤0.007%, enabling the detection of low frequency variants.
- TruSight RNA Fusion Panel – Provides comprehensive gene fusion detection in formalin-fixed, paraffin-embedded (FFPE) and other cancer research samples.
- TruSight RNA Pan-Cancer – Targeting 1385 oncology genes for gene expression, variant and fusion detection in all RNA sample types including FFPE.
- TruSight Tumor 15 – Focused panel to assess relevant solid tumor somatic variants in a simple, sample-to-data workflow.
See All Cancer Research Sequencing Panels
Exclusive Offer for TruSight Oncology 500
Purchase the TruSight Oncology 500 assay for the first time and receive an exclusive limited time offer.
Learn More
Systems and Software for Cancer Research
Find the optimal instrument and analysis software tools for your cancer research project.
Featured Products:
- DRAGEN Bio-IT Platform: Provides ultra-rapid secondary analysis of NGS data. Offers a variety of analysis options, including somatic and germline pipelines.
- BaseSpace Sequence Hub: A powerful, economical genomics cloud computing environment to manage, analyze, and share data.
See All Software & Informatics Products
Cancer Research Services
Find a lab that provides demonstrated proficiency with Illumina next-generation sequencing systems to support genetic and genomic research, including cancer research.
Find a Service Provider
Learn More
FFPE RNA-Seq
Next-generation RNA-Seq methods enable researchers to access valuable data from degraded and FFPE-derived samples.